rs755213252
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_213607.3(CCDC103):c.329G>A(p.Arg110Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000415 in 1,614,096 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_213607.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC103 | ENST00000417826.3 | c.329G>A | p.Arg110Gln | missense_variant | Exon 4 of 4 | 1 | NM_213607.3 | ENSP00000391692.2 | ||
CCDC103 | ENST00000410006.6 | c.329G>A | p.Arg110Gln | missense_variant | Exon 4 of 4 | 2 | ENSP00000387252.1 | |||
CCDC103 | ENST00000357776.6 | c.329G>A | p.Arg110Gln | missense_variant | Exon 4 of 4 | 2 | ENSP00000350420.2 | |||
CCDC103 | ENST00000410027.5 | c.*79G>A | 3_prime_UTR_variant | Exon 4 of 4 | 4 | ENSP00000386640.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152206Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251428Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135894
GnomAD4 exome AF: 0.0000445 AC: 65AN: 1461890Hom.: 0 Cov.: 32 AF XY: 0.0000413 AC XY: 30AN XY: 727248
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74356
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Uncertain:2
The p.R110Q variant (also known as c.329G>A), located in coding exon 3 of the CCDC103 gene, results from a G to A substitution at nucleotide position 329. The arginine at codon 110 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
This sequence change replaces arginine with glutamine at codon 110 of the CCDC103 protein (p.Arg110Gln). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and glutamine. This variant is present in population databases (rs755213252, ExAC 0.08%). This variant has not been reported in the literature in individuals affected with CCDC103-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at